When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions The Blacklisting of Peptides FDA July 2026 Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety Meto blog Peptides in 2026, What the FDA Review Means Olympia Pharmaceuticals FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of Obesity Management Clinical Drug Topics